Spatial organization of signal proteins in specialized cholesterol and glycosphingolipid-enriched microdomains (lipid rafts) provide specificity in lymphocyte signalling. Src kinases associate with lipid rafts on the basis of their dual acylation in the N-terminus and initiate T cell signalling. The immunomodulatory signal enzyme protein kinase A (PKA) is a serine/threonine kinase that controls a number of processes important for immune activation by phosphorylation of substrates that alters protein-protein interactions or changes the enzymatic activity of target proteins in T cells. PKA substrates involved in immune activation include transcription factors, members of the MAP kinase pathway, phospholipases and the Src kinase Csk. The PKA type I isoenzyme localizes to lipid rafts during T cell activation and modulates directly the proximal events that take place after engagement of the T cell receptor. The most proximal and major target for PKA phosphorylation is the C-terminal Src kinase Csk which initiates a negative signal pathway that fine-tunes the T cell activation process.
ABSTRACT
Spatial organization of signal proteins in specialized cholesterol and glycosphingolipid-enriched microdomains (lipid rafts) provide specificity in lymphocyte signalling. Src kinases associate with lipid rafts on the basis of their dual acylation in the N-terminus and initiate T cell signalling. The immunomodulatory signal enzyme protein kinase A (PKA) is a serine/threonine kinase that controls a number of processes important for immune activation by phosphorylation of substrates that alters protein-protein interactions or changes the enzymatic activity of target proteins in T cells. PKA substrates involved in immune activation include transcription factors, members of the MAP kinase pathway, phospholipases and the Src kinase Csk. The PKA type I isoenzyme localizes to lipid rafts during T cell activation and modulates directly the proximal events that take place after engagement of the T cell receptor. The most proximal and major target for PKA phosphorylation is the C-terminal Src kinase Csk which initiates a negative signal pathway that fine-tunes the T cell activation process.
INTRODUCTION
Engagement of the T cell receptor/CD3 (TCR/CD3) complex can lead to a wide range of responses spanning from anergy and apoptosis to T cell activation with cytokine production, cytotoxic activity and proliferation. An optimal immune response requires the antigen to be presented to the T cell by an antigen presenting cell (the primary stimulus) in conjunction with a costimulatory stimulus (the secondary stimulus, e.g. CD28 or IL-2). Engagement of the TCR/CD3-complex elicits a signaling cascade in the T cell that involves numerous signaling molecules including protein tyrosine kinases (PTKs), protein tyrosine phosphatases (PTPs), G-proteins, GEFs and adaptor molecules (1, 2) . The first event is activation of the Src family PTKs Lck and Fyn, which subsequently leads to phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) present in the ζ, ε, δ and γ subunits of the TCR/CD3 (3, 4) . The phosphorylation of the ITAMs promotes recruitment and subsequent activation of the Syk-PTK ZAP- 70 . The activation of Src and Syk/ZAP-70 PTKs leads to phosphorylation of adaptor molecules and recruitment of enzymes facilitating the activation of downstream signaling pathways (2) . These events take place in specialized microdomains of the plasma membrane termed lipid rafts that have a high constituency of cholesterol and glycosphingolipids (5) . The activation cascade culminates in gene transcription, cytoskeletal rearrangement, cytokine production and proliferation.
Activation of cAMP signaling involves binding of an extracellular ligand to a G-protein coupled receptor (GPCR) which through G-proteins regulates one of several isoforms of adenylyl cyclase leading to generation of cAMP. Although other effectors of cAMP have been identified (6, 7) , the most versatile effector system is PKA. Ligand-induced changes in cAMP concentration vary in duration, amplitude and localization in the cell. Spatiotemporal organization of cAMP microdomains are created through coupled control of cAMP production by adenylyl cyclases in conjunction with phosphodiesterases that degrade cAMP. Different PKA isozymes with distinct biochemical properties and cell-specific expression contribute to cell and organ specificity (for review and references, see (8, 9) ). A kinase anchoring proteins (AKAPs) target PKA to specific substrates and distinct subcellular compartments providing spatial and temporal specificity for mediation of biological effects induced through the cAMP-PKA pathway (for review and references, see (10) (11) (12) ). AKAPs also serve as scaffolding proteins that assemble PKA together with signal proteins such as phosphatases and cAMP-specific phosphodiesterases as well as components of other signaling pathways into multiprotein signaling complexes that serve as crossroads for different signalling pathways. Targeting of PKA and integration of a wide repertoire of proteins involved in signal transduction into complex signal networks further increase the specificity required for the precise regulation of numerous cellular and physiologic processes. The cAMP-PKA pathway is strongly involved in the regulation and modulation of immune responses and is the most potent and acute inhibitor of activation of lymphocytes. Mechanisms of cAMP-mediated immunomodulation are discussed below.
LIPID RAFTS AS SIGNALING PLATFORMS
Cell membranes are mainly consisting of lipids assembled of polyunsaturated fatty acids that form a homogenous lipid double layer. In addition, the plasma membrane contains microdomains enriched in cholesterol and sphingolidids called lipid rafts or glycosphingolipidenriched membane microdomain (GEMs). One specific physical feature of these regions is their resistance to standard detergents like Triton-X100 in the cold. Hydrophobic interactions between long saturated fatty acids and sphingolipids keep the microdomains insoluble and permit their separation from the residual plasma membrane and other cell content by density-gradient centrifugation.
Lipid rafts have a submicroscopic size of around 3-4 nm and are assembled to form macrostructures that are micrometers in diameter during the formation of an immunological synapse, see e.g. (12) . This probably occurs due to rearrangement of the underlying actin cytoskeleton that anchors the lipid rafts. The connections of intermediate linker proteins between the membrane and the actin cytoskeleton are precisely regulated and provide an actin -raft cooperation. While most transmembrane proteins reside outside lipid rafts, some lipid-modified proteins associate specifically with lipid rafts. In particular, membrane proteins that take part in the proximal signaling events from the T cell receptor such as CD4, CD8, CD44, CD43 in addition to transmembrane adaptor molecules like LAT (linker for activation of T-cells), LIME ( Lck interacting membrane protein) and Cbp/PAG (CSk binding protein/Protein Associated with Glycosphinglipid-enriched membrane microdomains), localize to lipid rafts. Proteins without a transmembrane domain, but that are modified by lipids such as double acylation, also accumulate in rafts including Src-family kinases, PIP2 (13) and small Gproteins. Analyses of lipid raft purifications from normal resting T cells for the presence of different subunits of PKA also reveal both the catalytic subunit and the regulatory subunit RI a (but no RII subunits) to be constitutively associated with rafts (14).
INITIATION OF THE T-CELL SIGNALING CASCADE
T cells contribute to an immune response by both direct effector functions and by modulating the function of other cell types by cell-cell contact and secretion of cytokines. The functional properties of T cells are partly segregated into different subsets such as CD4 T cells, CD8 T cells and regulatory T cells and are further refined by the differentiation status of the particular subset. However, one single T cell is able to mount various responses depending on the antigen, the mode of activation and the specific microenvironment. A proper T cell response is essential for the maintenance of normal immune homeostasis and for an effective immune protection. Conversely, abnormalities in their function can lead to autoimmunity, allergic manifestations or immunodeficiencies.
The primary event leading to the activation and differentiation of T cells is the triggering of their antigenspecific T cell receptor (TCR) by a processed antigenic peptide presented by a major histocompatibility complex (MHC) class II molecule on the surface of an antigenpresenting cell (APC) or by a MCH class I molecule on a target cell. This event triggers several signal transduction pathways that involve second messengers, protein kinases, protein phosphatases and other enzymes and key intermediates (15) (16) (17) (18) . The signaling cascade culminates with the induction of gene transcription according to defined genetic programs that are characteristic of the different T cell subsets, leading to the differentiation and T cell proliferation. In addition, the proper development and selection of immature T cells in the thymus also depends on similar signaling events that determine the selection of T cells with the appropriate antigen specificity and affinity.
It is generally agreed that a key initiating event in T cell activation by antigen is the increased phosphorylation of ITAM tyrosines in TCR subunits by the Src family kinases Lck and Fyn (and perhaps c-Yes). Exactly how the TCR couples antigen recognition to this phosphorylation event is not clear. Proposed models include i) Juxtaposition of Lck to the TCR mediated by CD4 or CD8 (15, (19) (20) (21) (22) (23) (24) , ii) Increased local concentration of kinases and their substrates following receptor oligomerization and lipid raft coalescence (25-31), and iii) The active exclusion of Csk and PTPases (32). These mechanisms are not mutually exclusive, and probably all operate in concert.
Phosphorylated ITAMs in CD3 ζ serves to recruit PTK Zap70 (ζ-chain-associated protein 70 kDa), which subsequently phosphorylate LAT (linker for activation of T-cells), SLP76 (SRC-homology 2 (SH2)-domaincontaining leukocyte protein 76 kDa) and PLC γ1 (Phospholipase C γ1). The signaling cascade continues with the recruitment of (catalytic and non-catalytic) proteins such as Grb2 (Growth-factor-receptor-bound protein2), Gads (Grb2-related adaptor protein), the p85 subunit of PI3k, and NCK to LAT, that propagates intracellular signaling pathways that involves activation of RAS, PKC, mobilization of Ca
2+
, calcineurin and polymerization of the actin cytoskeleton. A complete immune response finally leads to activation of transcription factor NFkB (nuclear factor KB) and NFAT (nuclear factor of activated T-cells) initiating cytokine secretion and T cell proliferation (33-36)
SUPPRESSION OF Src-FAMILY PTKs BY Csk
Since Lck and Fyn play a pivotal role in the first signal events from the T cell receptor, it is not surprising that they are tightly regulated by multiple mechanisms (reviewed in (31,33)). Similar mechanisms are also present in other cell types that express different members of the Src family PTKs. An important mode of regulation of Srcfamily PTKs is by phosphorylation at a conserved tyrosine residue within the catalytic domain, Y394 in Lck and Y417 in Fyn(T). It is generally believed that Src-family PTKs autophosphorylate at this site, presumably in trans, but there is also evidence that another PTK may be involved (37). Phosphorylation at this site in Lck relieves an intramolecular block of substrate binding and also provides a conformational change in the so called "activation loop" (where Y394 resides) to position the catalytic amino acid residues for optimal catalysis (38). Although the stoichiometry of Y394 phosphorylation in intact T cells is very low (39,40), this event is crucial for substrate phosphorylation by Lck and for transformation by oncogenic Lck (41,42). The low stoichiometry is mainly due to rapid dephosphorylation (43).
Both Lck and Fyn (as well as other Src family PTKs) are negatively regulated by phosphorylation at a conserved C-terminal regulatory tyrosine residue, Y505 in Lck and Y528 in Fyn(T) (44,44,45). When phosphorylated, the tail tyrosine binds to the Src homology 2 (SH2) domain of the same kinase molecule thereby forcing it into an inactive conformation (46). The crystallization of Cterminally phosphorylated Src (47) and Hck (48) also revealed that the SH3 domain is important for stabilizing the kinase domain in the inactive conformation by binding to a region in the linker between the SH2 domain and the kinase domain. At least in T cell lines, approximately half of all Lck molecules are phosphorylated at Y505 (49), but changes in the phosphorylation status of Y505 have not been observed during T cell activation. Instead, the phosphotyrosine content of Lck increases after T cell activation (50) . This suggests that the activity of Lck in TCR signaling is not dependent on acute dephosphorylation at Y505.
The PTK responsible for the suppressive phosphorylation of Lck at Y505 and Fyn at Y528 is the Cterminal Src kinase (Csk), a widely expressed 50-kDa enzyme (51) (52) (53) (54) . At present, Csk is the only PTK known to have this specificity. The finding that disruption of the csk gene is lethal (55, 56) and that cells recovered from the early embryos contain greatly activated Src family PTKs, suggests that no other gene can fully compensate for the loss of csk during embryogenesis. Furthermore, both inducible knock outs and mature T cells with acute elimination of Csk exibit increased Src family kinase activation and are hyperresponsive to T cell stimuli (57-59). Nevertheless, it is possible that the other Csk family member Csk homologous kinase (CHK) also functioning as negative regulatory kinases of the SFKs (reviewed in (60)), may participate in the suppression of Src family PTKs in other cell types.
Consistent with a negative role of Csk in the regulation of Src family PTKs, Chow and collaborators have demonstrated that overexpression of Csk in T cells leads to a marked reduction of TCR-induced tyrosine phosphorylation and IL-2 production. The activity of Csk required both the SH2 and SH3 domains and was further enhanced by targeting Csk to the plasma membrane (61) . One explanation for the requirement of the SH3 domain is that that Csk specifically associates through its SH3 domain with the PEST-enriched PTPase (PEP) and it's human ortolog lymphoid protein tyrosine phosphatase (LYP)) (62) . Thus, the targeting of Csk to the plasma membrane may not only increase its access to Src-related PTKs but also recruit PEP/LYP to the plasma membrane and improve its activity leading to dephosphorylation of membrane-associated proteins (e.g. Lck or Fyn).
In line with this, mice lacking PEP have exaggerated T cell expansion (63) and patients with a single-nucleotide polymorphism in the gene (PTPN22) encoding the LYP is associated with type 1 diabetes, rheumatoid arthritis, lupus, Graves thyroiditis, Addison disease and other autoimmune disorders (64) (65) (66) (67) . The disease associated-variant result in a R620W amino acid substitution in the SH3 binding sequence making LYP unable to bind Csk (64) . Furthermore, in addition to the loss of Csk binding, the autoimmune-predisposing allele is a gain-of-function mutant where LYP-R620W has higher catalytic activity and is a more potent negative regulator of T lymphocyte activation (68).
SPATIOTEMPORAL REGULATION OF Csk RELEASES Lck FROM INHIBITION AND ALLOWS T CELL ACTIVATION TO OCCUR
Csk has a similar intramolecular organization to that of Src family PTKs with SH3-, SH2,-, and kinase domains, but differs from the Src kinases by the lack of the C-terminal regulatory tyrosine and autophosphorylation sites as well as the N-terminal lipid modification sequence that targets members of the Src kinase family to membranes. For that reason, it has for some time been unclear how this ubiquitously expressed cytosolic kinase effectively regulates the membrane associated Src kinases Lck and Fyn even though Csk has been shown to target to sites of Src activity in fibroblasts (69) . The cloning and characterization of a transmembrane adapter protein, Csk binding protein (Cbp) or Phosphoprotein Associated with Glycosphingolipid enriched membrane domains (PAG), associated with lipid rafts has revealed new insight into the Csk-mediated regulation of Src kinases (70, 71) . Cbp/PAG binds to the SH2 domain of Csk and was originally observed as an 80-kDa phosphoprotein present in lipid rafts (72, 73) . It is ubiquitously expressed and likely interacts with actin filaments through the EBP50-ERM protein complex (74, 75) . Furthermore, Cbp/PAG has a palmitoylation site and a cytoplasmatic tail with 10 sites for tyrosine phosphorylation that is phosphorylated primarily by Fyn in T cells (76) whereas Cbp/PAG dephosphorylation is mediated by CD45 or PTPα (77, 78) . Csk, Fyn and EBP50 are reproducibly found to interact with Cbp/PAG in vivo and Tyr317 (Tyr314 in mouse and rat) is identified as the binding site for the SH2-domain of Csk, while Fyn seems to interact independently of the Cbp/PAG phosphotyrosine status (76) . Interestingly, stimulation of T cells with antibodies towards CD3 alone or in combination with CD28 induces dephosphorylation of Cbp/PAG resulting in decreased Csk content in lipid rafts (32, 70) . We have further demonstrated that Csk association with Cbp/PAG is transient and corresponds with the kinetics of T cell activation (32). Overexpression of kinasedeficient Csk that displaces endogenous Csk from lipid rafts, have stimulatory effects on ζ-chain phosphorylation and IL-2 promoter activation both in resting T cells and after TCR triggering (32). Therefore, tonic suppression of Lck kinase activity in rafts by Csk seems to set the threshold for TCR signaling and appears important in order to avoid improper TCR signaling and T cell activation. Regulation of Csk kinase activity in rafts may therefore be crucial to prevent aberrant immune activation and autoimmunity. Although not completely understood, T cell activation requires transient dissociation of Csk from rafts, allowing Lck to become activated and to perform its catalytical functions, which provides an elegant mechanism for modulation of proximal TCR signaling (Figure 1) . However, Cbp/PAG knock out studies indicate that Cbp/PAG is dispensable both for embryogenesis and T-cell development and function and suggests that Cbp/PAG may be redundant and that other Csk binding proteins may exist in rafts (79, 80) .
Concomitant with the activation of Lck and dissociation of Csk from lipid rafts, Csk associates with a 72-kDa protein via its SH2 domain (81) . This protein was recently identified as G3BP, a phosphotyrosine-containing protein, reported to bind the SH3 domain of Ras GTPaseactivating protein and seems to serve to sequester Csk outside lipid rafts (82) . The formation of a complex of Csk and G3BP in T cells occurs within a time course that is similar to that of Csk-dissociation from Cbp/PAG upon TCR stimulation.
In addition, one major aspect in unraveling the processes controlling the initiation of TCR signaling would undoubtedly be the identification and characterization of the PTPases responsible for dephosphorylating Cbp/PAG. In addition to CD45 (83, 84) , the protein-tyrosine phosphatase Shp-2 appears to be involved in the phosphorylation status of the Csk-adaptor protein Cbp/PAG (85). C-terminal tyrosines are hyperphosphorylated in Shp-2 deficient cells which leads to decreased tyrosine phosphorylation in substrates of the Src family kinases. Shp regulates both the activation of Src family kinases and the activation of Ras/Erk signalling pathway.
REGULATION OF PROXIMAL T-CELL SIGNALING BY PKA TYPE I
Prostaglandin E 2 (PGE 2 ) and other ligands that lead to cAMP production by binding to G protein-coupled receptors inhibit TCR-induced T cell activation and thereby exert important immunoregulatory functions (86) . Based on studies with selective agonists, activation of protein kinase A (PKA) type I (RIα 2 C 2 ) has been shown to be necessary and sufficient for mediating these effects of cAMP (87, 88) . Similarly, PKA type I negatively regulates activation of B cells through the B cell antigen receptor (89) and NK cell cytotoxicity elicited through specific NK cell receptors (90) . Although PKA can modulate TCR signaling at multiple levels (reviewed in (91)), the observed inhibitory effects of cAMP on TCR-induced ζ-chain phosphorylation point towards an important role for Csk, which is the most up-stream PKA target reported so far. PKA phosphorylates S364 in Csk and induces a 2 to 4-fold increase in phosphotransferase activity of Csk in lipid rafts of T cells (14) (Figure 2 ).
Analyses of lipid raft purifications from normal resting T cells for the presence of different subunits of PKA, revealed that both the catalytic subunit and the regulatory subunit RIα (but no RII subunits) are constitutively associated with the lipid rafts (14) . Similarly catalytic subunits Cα and Cβ2 associate with lipid rafts ((92) and our unpublished data). This suggests that the colocalization of PKA type I and TCR in capped T cells (88) occurs in lipid rafts and that there are mechanisms for specific targeting of PKA type I to these areas that involves interaction with an AKAP in lipid rafts (our unpublished results). However, other possibilities include anchoring of the PKA catalytic subunit via the N-terminal myristyl group into rafts, or via interactions with a caveolin-like protein in T cell rafts, similar to the PKA Cα interaction with caveolin in other cell types (93) .
Studies of the organization of G proteins in the plasma membrane have revealed that in addition to G proteins, lipid rafts also contains adenylyl cyclase activity (94) . In fact, a substantial fraction of the total isoproterenol or forskolin-stimulated adenylyl cyclase in S49 lymphoma cells is present in these fractions, strongly suggesting that the receptor-G protein and G protein-adenylyl cyclase coupling occur in lipid rafts, and similar data have been obtained for normal T cells and HEK293 cells (95) . This implies that the entire molecular machinery required for generation of cAMP and activation of PKA type I after engagement of G-protein coupled receptors is recruited to lipid rafts and organized in a receptor-G-protein-ACcAMP-PKA type I-Csk pathway scaffolded by an AKAP and Cbp/PAG (Figure 2 ).
REGULATION OF Csk ACTIVITY, A MOLECULAR MECHANISM FOR THE INHIBITORY EFFECT OF cAMP ON IMMUNE FUNCTIONS
So far, two different mechanisms are reported to regulate Csk activity. PKA, through phosphorylation of Figure 3 . PKA and PDE4 have opposing functions in proximal T cell signalling. We propose a model where full T cell activation is prevented upon TCR triggering alone due to G protein coupling to the adenyl cyclase (AC) and generation of cAMP. Increased cAMP levels lead to activation of PKA, phosphorylation and activation of Csk and inhibition of Lck (a). However, CD28 co-stimulation down-modulates the TCR-induced cAMP-mediated inhibitory signals through recruitment of a β-arrestin/PDE4 complex leading to cAMP degradation and thus allowing a full T cell response to occur (b).
Ser-364 increases Csk kinase activity 2 to 4-fold leading to reduced Lck activity and ζ-chain phosphorylation. The other mechanism involves the adaptor molecule Cbp/PAG. Cbp/PAG recruits Csk to the site of action in lipid rafts (70, 71) , and the interaction between Csk-SH2 and Cbp/PAG through phosphorylated Y314/Y317 (rat/human Cbp/PAG) increases Csk activity (96) . Addition of either recombinant Cbp/PAG or peptides corresponding to the Csk-SH2 binding site significantly increased Csk kinase activity towards a Src substrate in vitro. Thus, PKA phosphorylation of Csk and interaction with Cbp/PAG may act together in turning on Csk activity, providing a powerful mechanism for terminating activation through antigen receptors dependent on Src kinase signaling ( Figure  2) . Interestingly, the cAMP inhibitory pathway has also been shown to be affected in several disease conditions. T cells from HIV infected patients have elevated levels of cAMP and hyperactivation of PKA (97) . Targeting of the cAMP-PKA type I pathway by selective antagonists improves the T cell function ex vivo (97, 98) and targeting cyclooxygenase 2 to reduce PGE 2 production lowers cAMP and increases T cell function in vivo  ((99,100) ). A similar mechanism contributes to the T cell dysfunction in a subset of patients with common variable immunodeficiency (CVI) (101) , and to the severe T cell anergy in a murine immunodeficiency model termed MAIDS (mouse AIDS) (102).
UNCOUPLING FROM cAMP IMMUNOMODULATION BY RECRUITMENT OF A PHOSPHODIESTERASE THAT DEGRADES cAMP
On the basis of the inhibitory role of cAMP, one might expect the intracellular level of cAMP to fall upon T cell activation. However, more than 15 years ago, the intracellular cAMP levels were reported to increase following T cell activation in the presence of the PDE inhibitor IBMX (86, 103) . Both the significance of activation-induced cAMP production and the intracellular location where cAMP production takes place, has been illunderstood to date. However, we have recently shown that T cell activation leads to rapid production of cAMP in lipid rafts in a G-protein dependent fashion, resulting in raftassociated PKA activation (104) ( Figure 3A) .
The spatiotemporal regulation of intracellular cAMP gradients is a result of the combined action of adenylyl cyclases and PDEs, which provide the sole route of cAMP degradation (105) (106) (107) . The importance of PDE action in T cells is clearly evident from both previous studies by other investigators (108) (109) (110) (111) and also from our experiments showing that PDE inhibition augments the increase in cAMP caused by T cell activation (112) . Not only are PDE4 enzymes the main contributors of cAMP-PDE activity in T cells (108) but PDE4 selective inhibitors exert a major component of their anti-inflammatory action through attenuation of T cell function (113, 114) . Thus one might expect that PDE4 activity would serve to promote T cell activity by reducing cAMP levels in the appropriate intracellular compartment. It is therefore interesting that TCR stimulation lead to increased adenylyl cyclase activity and cAMP production (87, 115) . However, we have recently shown that cAMP production elicited by TCR engagement is ablated upon CD28 co-stimulation. CD28 co-stimulation recruits PDE4 to the lipid raft fraction. Recruitment of PDE4 to rafts is accompanied by recruitment of β-arrestin, which in various other cell types has been shown to play an important role in uncoupling the receptor-mediated stimulation of G s (116) and allowing the receptor-mediated recruited of PDE4 isoforms (117, 118) .
In addition to recruitment of PDE4 isoforms to lipid rafts upon T-cell stimulation, it is possible that phosphorylation of PDE4 could further contribute to the increased phosphodiesterase activity. The activity of the long PDE4A4 isoform has been shown to be improved by about 25% through phosphorylation by PKA (119, 120) and the activity of the short PDE4B2 and PDE4D1 isoforms can be similarly improved through the action of ERK (121) , which becomes activated upon TCR stimulation (122) . However, the paucity of PDE4 protein in rafts makes a direct demonstration of this using either direct phosphorylation or the use of phospho-antibodies difficult. There are also other PDEs found in T cells (109, 123) , but no change in the activity of PDE3 was detected in lipid rafts upon TCR co-stimulation. PDE7 has been suggested to be important for T cell proliferation as it is up-regulated during the first eight hours of T cell activation. However, it is absent from resting T cells (123) and T cell functioning has recently been shown to be normal in knockout mice (124) indicating that PDE7 is unlikely to be involved in the regulation of the initial T cell signaling events.
Stimulation of the TCR is known to induce a signal that is too weak to fully activate T cells (125) . The signal can, however, be amplified by CD28 co-stimulation and together these two signals is able to induce full T cell activation and clonal expansion (126) . It is therefore interesting that CD28-induced recruitment of β-arrestin and PDE4 appears to play a key role in constraining TCR-induced adenylyl cyclase activation by recruitment of PDE4 in complex with β-arrestin (104) ( Figure 3B ). The recruited β-arrestin may also serve an uncoupling role, although the demonstration of this and the identification of its partner allowing recruitment will be a challenge for future studies. Since anti-CD3 and anti-CD28 co-stimulation recruits and activates PDE4 to a greater extent than anti-CD3 stimulation alone, signal-amplification by co-stimulation may be mediated through activation of unknown molecules in addition to identified species such as PI3-kinase, Itk and Vav-1 (125) . We suggest an additional role for CD28 as a molecular amplifier of TCR-induced signals whereby CD28 mediates PDE4 recruitment to lipid rafts and thereby suppress the inhibitory action of cAMP signals (Figure 3 ).
SUMMARY AND PERSPECTIVES
The activities of both PKA and PDE4 seem to be important for regulation of TCR-induced signalling and T cell function. PKA is activated by external stimuli such as PGE 2 and adrenergic agonists as well as by an intrinsic mechanism upon TCR stimulation both of which induces cAMP production in lipid rafts and inhibits proximal T cell signaling ( Figure 3A) . However, overexpression of PDE4 isoforms or β-arrestin has been demonstrated to increase T cell activation revealing regulatory roles for both proteins in T cell signaling, and a PDE4/β-arrestin complex is recruited to lipid rafts in response to a CD28 co-signal. We propose a novel role for TCR and CD28 co-stimulation in down-modulation of TCR-induced cAMP-mediated inhibitory signals through the recruitment of β-arrestin and PDE4 to lipid rafts and thus allowing a full T cell response to occur ( Figure 3B ).
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